A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

NCT04121143 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

120

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor's decision

Conditions

Plaque Psoriasis

Interventions

BIOLOGICAL: IL-17A Antagonist
BIOLOGICAL: Placebos

Sponsor

Jiangsu HengRui Medicine Co., Ltd.